Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-20-014068

EVP, Chief Technology Officer acquired 2,181 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lingamneni Anila EVP, Chief Technology Officer 2020-04-15 Grant or award +2,181 2,181 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lingamneni Anila EVP, Chief Technology Officer 2020-04-15 Grant or award · Non-qualified Stock Option (Right to Buy) +7,509 7,509 D: show line 2 in the form
Loading xslF345X03/form4.xml…